echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > JCEM: Vitamin D status and risk of death from whole causes and specific causes

    JCEM: Vitamin D status and risk of death from whole causes and specific causes

    • Last Update: 2020-07-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Although a negative correlation between vitamin Dstatus and mortality has been reportedin observational studies, the exact pattern of correlation and optimal vitamin D status has not yet been determinedRecently, the authoritative journal journal of endocrine and metabolic diseases published a study aimed at identifying the link between vitamin D status and the risk of death from whole causes and specific causes, and estimating the optimal serum 25-hydroxyvitamin D (25 (OH) Dthe prospective cohort study was based on the UK Biobank and involved 365,530 individuals with ahistory of serum 25 (OH) D at baseline (2006-2010), nocardiovascularvasculardisease (CVD), cancer ordiabetesThe main observations of the study were mortality for whole causes and for specific causes10,175 deaths occurred during the median follow-up period of 8.9 years (with a quadrial pitch of 8.3-9.5), including 1,841 deaths from CVD (18.1%) and 5737 deaths from cancer (56.4%)Multiple analyses revealed a non-linear negative correlation, with a decrease in the risk of death appearing to level off at 25 (OH) D levels of 60 nmol/L for whole causes and CVD deaths, and a reduced risk of cancer death at 45 nmol/LCompared to subjects with concentrations below the threshold of 25 (OH) D, the total mortality rate of high concentration subjects decreased by 17% (0.83, 95% CI was 0.79-0.86), CVD mortality decreased by 23% (HR was 0.77, 95% CI was 0.68-0.86), and cancer mortality decreased by 11% (HR 0.89, 95% CI 0.84-95), higher concentrations of 25 (OH) D were not linearly related to lower risk of all-cause, CVD, and cancer deathThe threshold of 45-60 nmol/L may be an intervention target to reduce the overall risk of early death, which needs to be further identified in large clinical trials
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.